INSIGHTS ON DRUG DEVELOPMENT
-
Accelerated Yield Optimization Of Affinity Capture
High‑throughput affinity screening shows how buffer and pH optimization can boost AAV5 recovery, enabling faster, more reliable downstream process development for challenging serotypes.
-
Extractables And Leachables: Setting Up Early For Success With Your CDMO
Discover insights tailored specifically for drug product researchers and manufacturers, offering key knowledge on extractables, leachables, and effective implementation strategies.
-
Predicting Hepatotoxicity With The Liver-Chip
Enhance your understanding of liver organoids and their pivotal role in enhancing DILI risk prediction through the use of advanced Organ-Chip technology.
-
EMA Support For SMEs Through Scientific Advice And Early Dialogue
Discover how early engagement with European regulators helps smaller drug developers reduce uncertainty, clarify requirements, and de‑risk innovative programs through early dialogue.
-
Maintain Control Of Pharmaceutical Water Systems4/10/2026
Early TOC excursions often reveal hidden risks in water systems. Capturing samples at the moment of deviation helps teams confirm root causes faster, reduce uncertainty, and maintain control.
-
Rapid Walkaway Solution For Assessing Viability In Cancer Organoids3/31/2025
Assess anti-cancer compounds' effects on organoid size and morphology with colorectal cancer organoids as well as discover automated imaging and viability assays to streamline drug screening and aid early identification.
-
Development Of A Non-Standard Protein Therapeutic2/4/2026
Discover how a tailored development approach transformed a complex therapeutic protein into a candidate ready for early-stage clinical trials.
-
Direct qPCR Amplification From Human Urine Samples6/9/2026
Extraction-free qPCR enables faster, lower-cost detection of UTI-associated bacteria directly from urine samples. Explore how this approach simplifies workflows and accelerates time to results.
-
Predictive Human Biology At Scale8/7/2024
Watch to explore applications of the Colon Intestine-Chip in studying cytokine-mediated inflammation, the effectiveness of anti-inflammatory therapies, and forthcoming immune cell recruitment.
DRUG DEVELOPMENT SOLUTIONS
-
Optical microscope Leica DM2500 LED
Leica DM2500 LED optical microscopes are tools for demanding tasks in life science routine and research applications. With their transmitted light illumination, optical performance, and state-of-the-art accessories, they are especially well-suited for challenging life science research tasks that require differential interference contrast or high-performance fluorescence.
-
Discover three solutions that provide the performance, reliability, and ease-of-use required for the most demanding applications in drug discovery, protein-protein interactions, structure-function characterization, and more.
-
Observe how comprehensive R&D support advances therapeutic oligonucleotides from discovery through commercialization with tailored formulation development services across multiple modalities and delivery platforms.
-
Optimize your cell line strategy for better viral vector production.
-
Advanced nanotechnology improves biologics with higher drug loads, better stability, new delivery routes, and enhanced performance in injectables, inhalation, and long‑acting therapies.